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doi:10.1016/j.ejvs.2011.04.013Abstract Introduction: Coxiella burnetii is a strict intracellular pathogen causing Q fever,
a worldwide zoonosis with an extensive animal reservoir. Chronic Q fever infections are
frequently associated with cardiovascular complications, mainly endocarditis, and also aortic
aneurysms and vascular-graft infection. We present four cases of chronic Q fever infections
and associated vascular complications, and review the literature to identify major symptoms
and assess the prevalence, treatment and outcome in these challenging patients.
Materials and methods: The demographic and clinical data of four patients presenting at our
unit were analysed. PubMed was searched to identify articles describing patients with chronic
Q-fever-associated vascular complications.
Results: Combining our own with the published experience, 58 cases (49 male) of chronic
Q-fever-associated vascular complications were identified. The average age of the patients
was 64 years (range: 30e83 years). As many as 26 patients had vascular graft infections (25
Dacron/polytetrafluoroethylene (PTFE), one homograft) and 32 had infected aneurysms. The
majority of these patients presented with fever (n Z 40) and/or pain (n Z 43). Weight loss
and fatigue were seen in 25 and 14 patients, respectively. Aneurysm rupture, aorto-enteric
fistulae and lower-limb embolisation were seen in nine, four and four patients, respectively.
Concurrent endocarditis was seen in two patients, whereas, for 15 cases, this information
was not available. Patients were treated with antibiotics for an average of 23 months (range
1e54 months). Treatment of infected vascular segments was described in 50 patients. Ten
patients were treated conservatively whilst 40 underwent resection of the infected vessel
and reconstruction with a graft. Major surgical complications (graft infection, n Z 3;aorto-
enteric fistula, n Z 2; bleeding, n Z 1; anastomotic leakage, n Z 1; aortic dissection,
nZ 1; vertebral osteomyelitis, nZ 3; graft thrombosis, nZ 1; renal failure, nZ 2; and pneu-
monia, n Z 1) were reported in 11 cases (21%) and were not specified in 13. The overall
mortality was 24% (14/58). Seven (18%) surgically treated patients died. Six of them died08888100.
.nl (M.C.A. Wegdam-Blans).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Vascular Complications of Q-fever Infections 385within 6 months of surgery and one patient at 3 years’ follow-up. Seven out of 10 of the conser-
vatively treated patients died within 3 years of diagnosis.
Conclusion: Aneurysms associated with Q-fever infections tend to be complicated, requiring
challenging surgical corrections, and long-term antibiotic treatment. Major complications
and mortality rates are significant, especially in conservatively treated patients.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Coxiella burnetii is a strict intracellular pathogen causing
Q fever, a worldwide zoonosis with an extensive animal
reservoir. Acute and chronic Q-fever infections have distinct
clinical sequelae and serological profiles, and require
different treatment strategies.1 The acute form of the
disease remains asymptomatic in approximately 60% of
cases. The clinical presentation of acute symptomatic cases
is mostly nonspecific. Symptoms may include flu-like mani-
festations, such as self-limiting fever, headache, myalgia,
atypical pneumonia and hepatitis. Encephalitis, pericarditis
and myocarditis are rare reported manifestations of acute
Q-fever infections.2 Chronic Q infections may evolve from
acute infections in some hosts with compromised immune
systems (leukaemia, cancer and human immunodeficiency
virus (HIV) infection), cardiac valvulopathy, aortic aneu-
rysms or prosthetic vascular grafts. Indeed, approximately
1.5e11% of patientswith acuteQ feverwill develop a chronic
infection.2e4 Endocarditis is the main manifestation of
chronicQ infection occurring in 60e70%of all cases, followed
by vascular infections, bone infections and chronic hepa-
titis.5 It has been estimated that approximately 7% of chronic
C. burnetii infections involve patients with aneurysms or
vascular graft.2,6
Outbreaks of C. burnetii infections in dairy goat farms
occurred from 2007 till 2009 in the Dutch provinces of
Noord Brabant and Gelderland, the catchment area of our
vascular service. This was followed by an increased inci-
dence of acute human Q-fever cases in the same region
during 2007.7 Since then, an exponential increase of Q fever
cases has been observed. In 2007, 168 new cases were
identified nationwide compared with 2354 new cases in
2009, most of them concentrated in our catchment area.
This resulted in an increased prevalence of chronic
C. burnetii infections and a consequential rise in the
prevalence of vascular patients with chronic Q fever.8
The purpose of this study was to identify important
symptoms of patients with vascular infections with C, bur-
netii to give clinicians, especially in an endemic area, tools
for accurate diagnosis.Materials and Methods
The demographic, clinical and laboratory data of four
patients presenting at our unit with chronic Q-fever-asso-
ciated vascular complications were extracted from their
electronic patient charts (CS-EZIS, ChipSoft, Amsterdam,
The Netherlands). The detection of chronic C. burnetii
infections was based on serology and/or polymerase
chain reaction (PCR) of tissue (if available) or blood (serum
or plasma). A commercially available immunofluorescenttest was used to detect C. burnetii phase I and II immu-
noglobulin G (IgG) antibody titres (Focus, Diagnostics, USA).
A positive result both for IgG phase I and II antibodies was
defined as having a titre of 1:32 or more. PCR analysis was
performed as described by Schneeberger et al.9 In accor-
dance with a regional consensus, patients were considered
to harbour chronic C. burnetii infection when the IgG phase
I antibody titre was >1024 and equal or greater to the IgG
phase II antibody titre,10 or if C. burnetii DNA was detected
in blood or tissue by a C. burnetii-specific PCR test.11
PubMed, tripdatabase, and sumsearch were searched for
articles describing theprevalence, treatmentandprognosis of
Q-fever-related vascular complications. The keywords
Q fever,Coxiellaburnetii, aorta, aneurysm,vascular andgraft
were used. Articles that described demographic and clinical
treatment and outcome data of chronic Q-fever patients with
vascular complications were selected. Reference lists of
selected articles were searched manually to retrieve missing
relevant publications. In case of duplicate publications, the
most recent report was included in this analysis.Results
Within a 3-month period, four patients with vascular
complications and chronic C. burnetii infection were
treated in our unit.
Case 1. An 83-year-old frail woman, suffering from Alz-
heimer’s disease, aortic- and mitral-valve insufficiency and
atrial fibrillation, was admitted with pneumonia. C-reactive
protein (CRP) was 39 mg l1 and leucocyte count was
5.5  109 l1. An extensive initial microbiological screen,
including blood cultures, was negative. However, in the
work-up for atypical pneumonia, C. burnetii serology was
negative for IgM but positive for IgG with significantly
elevated phase I and II titres (4096 and 4096, respectively)
and detection of C. burnetii DNA in plasma (Table 1).
She was treated with cefuroxime sodium IV for community-
acquired pneumonia and with doxycycline and hydroxy-
chloroquine for chronic Q fever. Abdominal ultrasound
revealed the presence of a 5.2-cm infrarenal aortic
aneurysm. Considering her frail condition, the abdominal
aortic aneurysm (AAA) was left untreated and no efforts
were made to rule out an endocarditis. She responded
well to medical therapy and was discharged to a geriatric
care facility after 6 weeks of hospitalisation. Six months
after hospital discharge, the patient remains alive and well.
Case 2. A 68-year-old man presented with a growing, non-
tender, fluctuating mass in his left flank/paravertebral
space. CRP was 24 mg l1 and leucocyte count was
Table 1 Results of different C.Burnetii-specific diagnostic test in our four cases.
IgM phase I&II titer IgG phase I titer IgG phase II titer PCR blood PCR tissue
Case 1 neg 1:4096 1:4096 pos na
Case 2 neg 1:4096 1:4096 neg pos
Case 3 neg 1:256 1:512 pos pos
Case 4 neg 1:2048 1:512 neg pos
Abbreviations: na: not available, neg: negative, PCR: polymerase chain reaction, pos: positive.
386 M.C.A. Wegdam-Blans et al.3.5 109 l1. An ultrasound scan revealed a large abscess. As
he had undergone emergency endovascular repair for
a symptomatic aorto-iliac aneurysm only 11 months previ-
ously, an abdominal computed tomography (CT) scan with
arterial contrast was obtained. This demonstrated the
presence of a paravertebral abscess extending to the left
psoas muscle but with no involvement of either the aorta or
the vertebral column. No endoleak was present. The abscess
was drained. Normal cultures of drained pus were repeat-
edly negative but C. burnetii DNA was detected by PCR in
this material. Serology confirmed the presence of chronic Q
fever with a C. burnetii IgG phase I titre of 4096 and phase II
titre of 4096 (Table 1). The patient was started on doxycy-
cline and hydroxychloroquine. Q-fever endocarditis was
ruled out by a negative transthoracic cardiac ultrasound
scan and negative plasma C. burnetii-specific PCR. Four
months after drainage of the abscess, the wound has almost
completely healed and the patient remains well, continuing
antibiotic therapy. Repeat CT angiography revealed a good
functioning graft with no signs of an endoleak.
Case 3. A 66-year-old woman with a previous tube-graft
repair of the ascending thoracic aorta for a type A aortic
dissection 3 years earlier was admitted with persisting
chest pain, anorexia and weight loss. CRP was 180 mg l1
and leucocyte count was 13.8  109 l1. Blood cultures
were negative. A CT scan with arterial contrast revealed
a 4.7-cm pseudo-aneurysm at the distal suture line. A
sternotomy was performed, resecting the distal part of the
tube graft and replacing it with a Dacron Gelweave
prosthesis. Cultures of the surgical specimens (native
aorta and graft) were positive for Bacteroides fragilis.
C. burnetii-specific PCR testing of the native aorta and
the resected tube graft were positive. The C. burnetii
IgG phase I and II antibody titres were 256 and 512,
respectively and IgM antibodies were not detected.
C. burnetii DNA was also detected by PCR in plasma (Table
1). Valvular vegetations were not seen on trans-
oesophageal cardiac ultrasound. She was started on
metronidazole, doxycycline and hydroxychloroquine and
has made a further uneventful recovery. The patient was
discharged from hospital on the 24th postoperative day.
Two months after surgery, she remains well and is
continuing antibiotic therapy.
Case 4. A 75-year-old man presented with a haemodynamic
collapse and abdominal pain. His prior medical history
included, among other things, percutaneous coronary
intervention and chronic obstructive pulmonary disease. Onabdominal CTscanwith arterial contrast, a ruptured saccular
infrarenal aortic aneurysm was seen with massive haemor-
etroperitoneum. An emergency laparotomy was performed
and the aorta was repaired with an inlay Dacron tube graft.
Preoperative blood tests (leucocyte count, CRP) were not
available. Cultures of resected aortic tissue and initial blood
cultures were negative. C. burnetii-specific PCR test of the
aortic tissue was positive but there were no traces of
C. burnetii DNA in plasma. C. burnetii serology was indica-
tive of chronic infection (phase I IgG titre 2048 and phase II
IgG 512, Table 1). Doxycycline and hydroxychloroquine
therapy was initiated. Postoperatively, the patient devel-
oped kidney failure and two episodes of haemodynamic
instability secondary to an Enterococcus faecium bacter-
aemia and a hospital-acquired pneumonia. He died on the
39th postoperative day from multiple organ failure.
A literature search identified 17 relevant articles
describing casesor case series of chronic vascularQ infections
(July 2010).8,11e26 Three articles presented previously pub-
lished data in combination with new cases. In total, 54 cases
of chronic vascularQ-fever infections have been reported. An
overview of these and our four cases is given in Table 2. They
compriseaheterogeneous groupofpatientswith thoracic and
abdominal aortic aneurysms, peripheral arterial aneurysms
and aortic or peripheral vascular grafts. The majority of
patients (nZ 43) suffered from pain (abdominal,nZ 36; and
lumbar, n Z 7) and had fever (n Z 40). Other nonspecific
symptoms, such as weight loss (nZ 25) and fatigue (nZ 14),
were common findings. Ten patients had spondylitis. Patients
frequently presented with vascular complications. There
were nine vascular ruptures, four aorto-enteric fistulas and
thrombo-embolic complications occurred in four cases. Para-
aortic abscesses were seen in seven patients (Table 3). The
majority of patients had no signs of endocarditis (n Z 41),
although, for 15 cases, this information was not mentioned.
Two patients had concurrent Q-fever endocarditis. One
of them developed a stroke due to ultrasonographically
detected vegetations of the aortic valve, 2 days after
aortic reconstruction. Another patient had aortic-valve
replacement 6 months prior to presenting with an infected
abdominal aortic aneurysm for which he underwent surgery,
but was considered endocarditis negative.
C. burnetii infection of an aneurysm was seen in 32
patients, whilst infection of a vascular graft was seen in 26
patients. The localisation of the infected aneurysm or graft
was the infrarenal aorta in 45 patients, the suprarenal aorta
in four, the thoracic aorta in six and the thoraco-abdominal
aorta in one patient. The splenic, femoral, popliteal and
subclavian arteries were all affected once (Table 4). Two
patients had aneurysms at two sites simultaneously, one
Table 2 Overview of clinical characteristics of 58 patients with chronic vascular C. burnetii infection.
Reference Case nr Gender Age Fever Presenting symptoms Vascular lesion Concurrent diagnosis
1 F 83 Yes Fever, dyspnoea, Asymptomatic AAA Community acquired pneumonia
2 M 68 No Paravertebral abscess, Asymptomatic EVAR Paravertebral abscess
3 F 66 No Chest pain, anorexia, weight loss Ruptured pseudoaneurysm ascending aortic tube graft
4 M 75 No Syncope, abdominal pain Ruptured saccular infrarenal AAA
12 5 M 65 Yes N, fatigue, weight loss, lumbar pain Growing infrarenal AAA Spondylitis
8 6 M 76 No Syncope, abdominal pain, hematemesis Infrarenal AAA Aortoduodenal fistula
13 7 M 58 Yes Fever, fatigue, weight loss Infrarenal bifurcated dacron graft
14 8 M 66 No Lumbar pain Pseudoaneurysm aortobifemoral dacron graft Periaortic abscess; spondylitis
15 9 M 63 No Abdominal pain Aortobifemoral dacron graft
16 10 M 54 No Abdominal pain, fatigue , anorexia Infrarenal AAA Spondylitis
17 11 M 30 Yes Fever Thoracic aortic goretex graft
18 12 M 75 No Hematochezia, abdominal pain, syncope Infrarenal AAA, Aortoduodenal fistula
19 13 M 35 Yes Fever, weight loss, dyspnea Splenic artery aneurysm, femoral artery aneurysm
20 14 M 47 No Acute limb ischemia, sweating Saccular aortoiliac aneurysm, popliteal aneurysm
20 15 M 55 Yes Asymptomatic Infrarenal aortoiliac aneurysm
21 16 M 61 Yes Limb ischemia Infrarenal aortic dacron graft
21 17 M 66 No Abdominal pain, hypotension Ruptured infrarenal AAA
22 18 F 49 No Back pain Thoracic aortic type B dissection
11,20,23 19 F 65 Yes Abdominal pain, weight loss Saccular suprarenal aortic aneurysm Hepatitis
11,24 20 M 65 Yes Myalgia, nausea, weight loss Subclavian dacron bypass graft
11,25 21 M 67 No Lumbar pain, weight loss Infrarenal aortic graft pseudoaneurysm
11 22 M 70 Yes Lumbar pain Infrarenal AAA
11 23 M 70 Yes Syncope Ruptured infrarenal AAA
11 24 M 76 No Abdominal pain, weight loss Infrarenal AAA
11 25 M 36 Yes Asymptomatic Ascending aortic aneurysm
11 26 M 78 No Limb ischemia, weight loss Infrarenal AAA
11 27 F 70 Yes Abdominal pain, weight loss Infrarenal AAA Renal insufficiency
11 28 M 68 Yes Weight loss Aortobifemoral dacron graft Hepatosplenomegaly
26
a
29e58 M: nZ26;
F: 4
66.4b Fever (n) 26 Lesion type: Not specified
Infected vascular graft nZ16Lumbar pain (n) 3
Abdominal pain (n) 28 Aneurysms nZ14
Lokalisation:
Infrarenal nZ24
Suprarenal nZ3
Weight loss (n) 14 Thoracic nZ2
Thoracoabdominal nZ1Fatigue (n) 11
Stroke (n) 2
Emboli (n) 2
Spondylitis (n) 7
Aortoduodenal fistula (n) 2
Paraaortic abscess (n) 4
Vascular rupture (n) 5
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Case nr Vascular treatment Adjuvant treatment Complication Antibiotic treatment
(duration in months)
Outcome
1 No No No Doxy (6) Alive @ 6 mo
2 No drainage of abscess No Doxy, Cqn (4) Alive @ 4 mo
3 Partial graft resection and replacement No Cardiac tamponade Doxy, Cqn (2) Alive @ 2 mo
4 Resection þ tube graft placement No Renal failure, septic
shock,pneumonia, death
Doxy, Cqn (1) Dead @ 1 mo
5 Resection þ Ag impregnated aortobifemoral
graft
No No Doxy, Levo, Rifa (24) Alive @ 24mo
6 Resection þ aortic tube graft placement Fistula closure Leg thrombosis, re-bleeding,
death
Noc Dead
7 Resection þ autologous vein graft interposition No No Targeted ABd(9) Alive @ 9 mo
8 Resection þ extraanatomic dacron bypass(2x
axillofem)
No No Doxy, Cirpo (24) Alive @ 24mo
9 Partial resection þ homograft No No Doxy, Cqn (18) Alive @ 18 mo
10 Resection þ cryopreserved homograft No No Doxy, Cqn(18) Alive @ 18 mo
11 Resection þ homograft No No Doxy, Oflox (10) Alive @ 10 mo
12 Aortobiiliac (?) rifampin soaked graft No No Doxy, Levo (10) Alive @ 10 mo
13 Splenic artery resection Splenectpmy, distal
pancreatectomy
Femoral aneurysm rupture,
death
Doxy, Fql (?)e Dead @ 6 mo
14 Aortobiiliac graft No Amaurosis fugax Doxy, Rifa, Oflox (54) Alive @ 13 y
15 Resection þ aortobiiliac prosthetic graft No No Cipro, Doxy (36) Alive @ 12y
16 No No Massive intraabdominal
bleeding, graftduodenal
fistula, death
Clinda(6) Dead @ 6 mo
17 Resection þ dacron tube graft placement No Anastomotic leak, renal
failure, death 2 mo po
Doxy (6) Dead @ 6 mo
18 Resection þ dacron graft interposition No Post op death Tetra (6) Dead @ 6 mo
19 Resection þ graft placement No No Doxy, Rifa (60) Alive @15y
20 Resection No No Doxy, Rifa (36) Alive @ 3 years
21 Bilateral axillofemoral Dacron
bypass þ resection
Drainage of abscess Vertebral osteomyelitis, Doxy, Oflox (48) Alive @ 4 years
22 Yes, not specified Not specified Graft infection, vertebral
osteomyelitis, aortoduodenal
fistula, death
Doxy (2) Dead @ 2 mo
23 Yes, not specified Not specified Graft infection, vertebral
osteomyelitis, aortoduodenal
fistula
Doxy (18) Alive @ 3 years
24 Yes, not specified Not specified No Doxy (18) Dead @36m
25 Yes, not specified Not specified No Doxy (28) Alive @28m
26 Yes, not specified Not specified Graft infection,
pseudoaneurysm
Doxy, Oflox (36) Alive @ 3 y
27 Yes, not specified Not specified No Doxy, Oflox (21) Alive @ 21m
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Vascular Complications of Q-fever Infections 389had an aortic and (thrombosed) popliteal aneurysm and one
patient presented with a splenic artery and a common
femoral artery aneurysm.
The diagnosis of C. burnetii infection was established by
serology in 45 patients. Isolation by culture of C. burnetii
from the tissue was diagnostic in three patients. Detection
of C. burnetii DNA in tissue or in blood established the
diagnosis in seven and three patients, respectively.
Patients were treated with a variety of (a combination of)
antibiotics. Themajority of patients received doxycycline as
monotherapy (n Z 18) or in combination with hydroxy-
chloroquine (n Z 22), ofloxacin (n Z 5), ciprofloxacin
(n Z 2), levofloxacin (n Z 1), fluoroquinolone (n Z 1),
rifampin (nZ 1), rifampin and ofloxacin (nZ 1) or rifampin
and levofloxacin (n Z 2). Tetracycline was given as mono-
therapy in one patient and clindamycin in another. Finally,
one patient was treated with a combination of clindamycin,
cefixim, doxycycline and hydroxychloroquine. One patient
received ‘targeted antibiotics’ and one patient who died
before the diagnosis could be established did not receive any
antibiotics at all. The duration of antibiotic treatment
averaged 23 months, varying between 0 and 66 months. In
general, patients were treated for at least 18 months.
Shorter treatment durations were reported for cases with
shorter follow-up periods or patients who had died.
In the majority of patients, but not all, the infected
aneurysm or graft was resected. The vascular treatment plan
was reported for 50 patients and remained unclear in eight
cases. Forty patients were treated surgically and 10 patients
were treated conservatively. Vascular treatment consisted of
resection of the infected aneurysm or graft mainly followed
by vascular reconstruction with a homograft or Dacron pros-
thesis in an anatomic or extra-anatomic position. In one
patient, an infected subclavianesubclavian polytetrafluoro-
ethylene (PTFE) cross-over bypass was resected without
further reconstruction. In one patient with a splenic and
femoral artery aneurysm, only the splenic artery aneurysm
was resected whilst the femoral aneurysm was left in situ.
Major surgical complications were reported in 11 cases
(Table 5), and 16 surgical patients recovered apparently
without complications. However, the presence or absence
of (surgical) complications was not specified in 30 cases.
A total of 14 (24%) fatalities were observed. Among the
patients who underwent resection of the infected aneu-
rysm or graft (nZ 40), seven died. Five patients died within
2 months of surgery. One patient with a splenic and femoral
artery aneurysm died from a rupture of the femoral aneu-
rysm, 6 months after splenic-aneurysm resection. Another
patient who had undergone resection of an infected aneu-
rysm died 3 years later from a ruptured pseudo-aneurysm.
In the group of patients, who were treated conservatively
(n Z 10), one patient died of a massive intra-abdominal
haemorrhage 6 months after being diagnosed with an
infected infrarenal aortic prosthesis. The remaining six
fatalities occurred in conservatively treated patients within
3 years of diagnosis. None of the eight patients with
unspecified vascular treatment (nZ 10) have died. If these
eight patients with uncertain vascular treatment are not
taken into account, the mortality in the conservatively
treated group is significantly higher than in the group of
patients whose infected aneurysm or graft has been
resected (7/10 vs. 7/40, chi square 4.98, P Z 0.025).
Table 3 Summary of presenting symptoms, vascular
treatment and mortality in 58 cases of chronic vascular
C.Burnetii infection
Symptom N (%)
Fever 40 (62)
Lumbar pain 7 (12)
Abdominal pain 36 (63)
Weight loss 25 (43)
Fatigue 14 (24)
Stroke 2 (3)
Embolization 4 (7)
Spondylitis 10 (17)
Aortoduodenal fistula 4 (7)
Paraaortic abscess 7 (12)
Vascular rupture 9 (16)
Graft pseudoaneurysm 3 (12)a
Surgery 40 (69)
No surgery 10 (17)
Uncertain treatment 8 (14)
Major post-operative complicationb 11 (39)
Mortality 14 (24)
a 3 pseudoaneurysms in 26 cases of graft infection.
b Major postoperative complications were not specified in 30
cases.
390 M.C.A. Wegdam-Blans et al.Two articles assessed the prevalence of chronic Q fever
in vascular patients. Fournier and colleagues screened all
patients (n Z 163) with aneurysms or vascular grafts
operated in their hospital between January 1995 and
December 1996.11 In two (1.2%) patients (one with an AAA
and one with a graft), C. burnetii was isolated from the
vascular specimen. Wever et al. screened 52 patients with
AAA in an endemic area and detected four (7.7%) patients
with a chronic C. burnetii infection for whom both serology
and PCR testing of blood was positive.8
Discussion
We reviewed the fate of 58 patients with vascular
(extravalvular) chronic Q-fever infections. It is a veryTable 4 Lesion type and lokalisation in 58 cases of
rchronic vascular Q fever
Lesion lokalisationa N (%)
Infrarenal aorta 45 (78)
Suprarenal aorta 4 (7)
Thoracic aorta 6 (10)
Thoracoabdominal aorta 1 (2)
Splenic artery 1 (2)
Femoral artery 1 (2)
Popliteal artery 1 (2)
Subclavian artery 1 (2)
Lesion type N (%)
Graft infection 26 (45)
Aneurysm 32 (55)
a 2 patients had aneurysms at 2 locations.heterogeneous group with a variety of vascular pathologies,
presenting with a range of nonspecific, systemic symptoms
and, not infrequently, with acute vascular complications.
The incidence of acute Q fever is low but may vary
considerably from 0.15 to 0.35/100 000 population per year
to 7.5e50/100 000population per year in areaswhereQ fever
is endemic.27 Approximately 1.5e11% of acute Q fever cases
will evolve to chronic Q fever.2e4 After Q-fever endocarditis,
vascular C. burnetii infection is the most frequent manifes-
tation of chronic Q fever, accounting for approximately 8% of
chronic cases.2,6 The low incidence of acute and chronic Q
fevermay explain the limited number of published reports of
patients with chronic vascular C. burnetii infections.
However, studies from France have shown that, despite the
low incidence of acute and chronic Q fever, seroprevalence
of specific anti-C. burnetii antibodies was 4% among blood
donors28 and as high as 30% in a small rural community.29
Moreover, Fournier et al. have shown that approximately
1.5% of patients with aneurysms or vascular grafts have
chronic Q fever,11 suggesting that vascular Q fever probably
remains underreported. A recent outbreak of C. burnetii
infections in the Netherlands resulted in an increased inci-
dence of Q fever from 168 cases nationwide in 2007e2354
new cases in 2009.7 This has resulted in an increase in the
number of chronic vascular Q cases in the region. In the
period in which we treated our four cases, seven more
patients with chronic C. burnetii infections and AAAs have
been identified in the same area.8 The regional incidence of
vascular Q infections among aneurysm patients has been
estimated to be as high as 8%.8 It should be noted that this
overview has shown that aneurysms and grafts in virtually
every major artery may be affected by chronic Q fever.
This review has indicated that chronic C. burnetii
infection of aneurysms and vascular grafts is associated
with significant mortality and morbidity. Treatment of
vascular Q infections seems to be based on two premises,
that is, resection of the infected aneurysm or graft and
long-term antibiotic therapy.
Currently, no guidelines exist for the antibiotic treatment
of vascular-Q-fever patients. This explains the great variety
of (combination of) antibiotics that has been used in the
published cases.30e34 Due to relapse on antibiotic with-
drawal, combinations of antibiotics has been proposed.
Combinations of doxycyclinewith fluoroquinolone, rifampin,
ofloxacin and (hydro)chloroquin have proven clinicallyTable 5 List of major surgical complications that
occurred in 11 patientsa
Death 5 (19%)
Renal failure 2 (7%)
Pneumonia 1 (4%)
Graft thrombosis 1 (4%)
Anastomotic leak/
pseudoaneurym
3 (11%)
Graft infection 3 (11%)
Vertebral ostomyelitis 3 (11%)
Aortoduodenal fistula 2 (7%)
a The presence/absence of surgical complications was repor-
ted in only 27 patients.
Vascular Complications of Q-fever Infections 391effective,27 but even after 3-year treatment intervals,
relapse of infection after antibiotic withdrawal remains
a problem, although it seems less so for the combination of
doxycyclin with chloroquin.35 The optimum duration of
antibiotic therapy for chronic Q endocarditis has not been
accurately determined. An acceptable consensus may be
administration of antibiotics for at least 18 months or until
phase I C. burnetii antibody titres have fallen significantly
(fourfold titre decline).27 We believe that in the absence of
evidence, the same antibiotic regime should be used for
chronic vascular C. burnetii infections.
Extrapolation of the lessons learned from the treatment
of Q-fever endocarditis to vascular C. burnetii infections
suggests, in the light of the significant relapse rates after
antibiotic withdrawal that surgical excision of the affected
vascular segment is an integral part of treatment. Surgical
excision of a C. burnetii-infected aneurysm or graft is
technically challenging, not in the least due to the
inflammatory reaction at the level of the diseased vascular
segment and the frequently occurring complications, such
as vascular rupture, pseudo-aneurysm formation, aorto-
enteric fistulae and paravascular abscesses. Moreover, the
chronic infection itself may have weakened the patient
prior to undergoing major surgery. This is corroborated by
the high rate of major surgical complications and substan-
tial surgical mortality reported in the published cases.
Bearing in mind the limitations of the data presented here,
it is suggested that surgery seems to confer a survival
benefit compared with antibiotic treatment alone in these
patients. This, however, may not apply for endovascular
aortic reconstructions, as, in that case, the diseased aorta
remains in situ. The second case from our institution pre-
sented with an abscess 11 months after endovascular
aneurysm repair for a symptomatic AAA. What was inter-
preted as fluid at the preoperative CT scan, may, in hind-
sight, be inflammatory tissue in reaction to Q-fever aortitis.
As the aneurysm/endograft showed no enhanced activity on
a fluoro-deoxyglucose positron-emission tomography com-
puted tomography (FDG PET CT) scan, we have chosen to
treat this patient conservatively with long-term antibiotics.
Only the future will indicate whether this has been the right
decision.
Conclusion
Chronic vascular C. burnetii infection is a complicated
disease with significant mortality and a high complication
rate. In patients with vascular pathology and general
nonspecific symptoms, C. burnetii infection should be
investigated. In endemic areas, it is wise to screen all
patients with vascular pathologies, particularly if the
patients present with general symptoms or rare (acute)
complications. Considering the low incidence of vascular
C. burnetii infections, we strongly support the develop-
ment of collaborative efforts to gather data from patients
with vascular Q fever systematically to create a sound
evidence base that will inform future clinical practice.
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